The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Open accessAbstract
Background —Some epidemiological studies have shown that increased iron stores are associated with increased cardiovascular events. Redox-active iron may contribute to lipid peroxidation, endothelial cell activation, and generation of reactive oxygen species (especially hydroxyl radical, via Fenton chemistry). Increased oxidative stress is associated with impaired action of endothelium-derived nitric oxide in patients with atherosclerosis. Methods and Results —To test the hypothesis that reducing vascular iron stores would reverse endothelial dysfunction, we examined the effects of the iron chelator deferoxamine (500 mg intra-arterially over 1 hour) on vasomotor function in forearm resistance vessels of patients with coronary artery disease by venous occlusion plethysmography. Patients with coronary artery disease had impaired endothelium-dependent vasodilation in response to methacholine compared with healthy control subjects ( P <0.001). Deferoxamine infusion decreased serum iron levels ( P <0.001). Deferoxamine improved the blood flow response to methacholine in patients with coronary artery disease ( P <0.01 by 2-way repeated-measures ANOVA) but had no effect on the response to sodium nitroprusside. In normal volunteers, deferoxamine had no effect on the response to methacholine. The nitric oxide synthase inhibitor N G -monomethyl- l -arginine abolished augmentation of the methacholine response associated with deferoxamine. The hydroxyl radical scavenger mannitol had no effect on the methacholine response. Conclusions —Deferoxamine improved nitric oxide–mediated, endothelium-dependent vasodilation in patients with coronary artery disease. These results suggest that iron availability contributes to impaired nitric oxide action in atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while iron chelation improves it [797-800].”
In the citing paper
“Iron chelation improves endothelial function”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Antioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B. B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
Self-citationSalonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992) · Circulation · doi:10.1161/01.cir.86.3.803 · Cited by 1,284
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,172
Self-citationOxidative Stress as a Regulator of Gene Expression in the Vasculature
KUNSCH, C. A., & Medford, R. M. (1999) · Circulation Research · doi:10.1161/01.res.85.8.753 · Cited by 801
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
Williams, S. B., Goldfine, A. B., Timimi, F. K., Ting, H. H., Roddy, M.-A., Simonson, D. C., & Creager, M. A. (1998) · Circulation · doi:10.1161/01.cir.97.17.1695 · Cited by 793
Nitric oxide and iron proteins
Cooper, C. E. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00021-3 · Cited by 510
Smith, C., Mitchinson, M. J., Aruoma, O. I., & Halliwell, B. (1992) · Biochemical Journal · doi:10.1042/bj2860901 · Cited by 455
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 14
- 10.1161/circ.86.3.1516192 · DOI
- 10.1161/circ.100.12.1268 · DOI
- 10.1161/circ.89.3.8124837 · DOI
- 10.1161/circ.96.10.3300 · DOI
- 10.1161/circ.99.9.1222 · DOI
- 10.1161/circ.99.7.852 · DOI
- 10.1161/res.85.8.753 · DOI
- 10.1161/circ.99.24.3118 · DOI
- 10.1161/circ.81.2.2105174 · DOI
- 10.1161/circ.97.8.736 · DOI
- 10.1161/hyp.35.4.936 · DOI
- 10.1161/circ.100.19.1951 · DOI
- 10.1161/circ.51.6.1132099 · DOI
- 10.1161/circ.97.17.1695 · DOI
Cited by
Sorted by citations
Items 101–200 of 270
Iron and Oxidative Stress in Renal Insufficiency
Lim, C. S., & Vaziri, N. D. (2004) · American Journal of Nephrology · doi:10.1159/000082201 · Cited by 34
Protective effect of EDTA preadministration on renal ischemia
Foglieni, C., Fulgenzi, A., Ticozzi, P., Pellegatta, F., Sciorati, C., Belloni, D., Ferrero, E., & Ferrero, M. E. (2006) · BMC Nephrology · doi:10.1186/1471-2369-7-5 · Cited by 33
Regulation of xanthine oxidoreductase by intracellular iron
Martelin, E., Lapatto, R., & Raivio, K. O. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00280.2002 · Cited by 33
Potential risk for infection and atherosclerosis due to iron therapy
Sengoelge, G., Sunder–Plassmann, G., & Hörl, W. H. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.09.018 · Cited by 32
Kom, G. D., Schwedhelm, E., Nielsen, P., & Böger, R. H. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.004 · Cited by 32
Effect of deferasirox (ICL670) on arterial function in patients with beta‐thalassaemia major
Cheung, Y., Chan, G., & Ha, S. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07092.x · Cited by 30
Haemochromatosis mutations and ferritin in myocardial infarction: a case‐control study
Claeys, D., Walting, M., Julmy, F., Wuillemin, W. A., & Meyer, B. J. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1003.x · Cited by 31
Synthetic and semi-synthetic antioxidants in medicine and food industry: a review
Tauchen, J., Huml, L., Jurášek, M., Regenstein, J. M., & Özoğul, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1599816 · Cited by 31
High dose intravenous iron: a note of caution
Kletzmayr, J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.6.962 · Cited by 30
The complex interplay between ferroptosis and atherosclerosis
Zhang, M., Li, J., & Hu, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117183 · Cited by 32
Goel, H., Hirsch, J. R., Deswal, A. M., & Hassan, S. A. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00960-1 · Cited by 29
Schaller, G., Scheiber‐Mojdehkar, B., Wolzt, M., Puttinger, H., Mittermayer, F., HuRl, W. H., Fadinger, M., Sunder–Plassmann, G., & Vychytil, A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00754.x · Cited by 29
Vlahos, A. P., Koutsouka, F. P., Papamichael, N. D., Makis, A. C., Baltogiannis, G., Athanasiou, E., Chaliasos, N., Bourantas, K. L., & Kolettis, T. M. (2012) · Acta Haematologica · doi:10.1159/000338825 · Cited by 29
Hosseini, B., Saedisomeolia, A., & Skilton, M. R. (2016) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.09.031 · Cited by 28
The incidental relationship between serum ferritin levels and hypertension
Ryoo, J., Kim, S. Y., Oh, C., Park, S. K., Kim, E., Park, S.-J., Yu, J. I., Kim, M., Choi, Y., & Ko, T. S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.152 · Cited by 27
Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro
Carlini, R. G., Alonzo, E., Bellorín-Font, E., & Weisinger, J. R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl341 · Cited by 27
Nematbakhsh, M., Pezeshki, Z., Moaeidi, B. A., Eshraghi-Jazi, F., Talebi, A., Nasri, H., Baradaran, S., Gharagozloo, M., Safari, T., & Haghighi, M. (2013) · Europe PMC (PubMed Central) · Cited by 26
Complex role of the HIF system in cardiovascular biology
Czibik, G. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0646-x · Cited by 27
Pócsi, I., Jeney, V., Kertai, P., Pócsi, I., Emri, T., Gyémánt, G., Fésüs, L., Balla, J., & Balla, G. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700467 · Cited by 25
Iron metabolism and regulation by neutrophil gelatinase-associated lipocalin in cardiomyopathy
Chan, Y. K., Sung, H. K., & Sweeney, G. (2015) · Clinical Science · doi:10.1042/cs20150075 · Cited by 27
Intravenous iron therapy in renal failure: Friend and foe?
Afzali, B., & Goldsmith, D. J. A. (2004) · Journal of Nephrology · doi:10.1093/joneph/17.4.487 · Cited by 25
Iron chelators may help prevent photoaging
Kitazawa, M., Iwasaki, K., & Sakamoto, K. (2006) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2006.00218.x · Cited by 25
Intravenous iron therapy: well‐tolerated, yet not harmless
Sengölge, G., Hörl, W. H., & Sunder–Plassmann, G. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01530.x · Cited by 24
Yoshida, H., Sasaki, K., Hirowatari, Y., Kurosawa, H., Sato, N., Furutani, N., & Tada, N. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.03.018 · Cited by 23
Cardiac complications in thalassemia throughout the lifespan: Victories and challenges
Wood, J. C. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15078 · Cited by 24
Figarola, J. L., Scott, S., Loera, S., Xi, B., Synold, T. W., Weiss, L. M., & Rahbar, S. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.550 · Cited by 21
Anderson, R. M., Dart, A. M., Starr, J., Shaw, J. A., & Chin-Dusting, J. P. F. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.009 · Cited by 22
Stiffness of the Abdominal Aorta in β-Thalassemia Major Patients Related With Body Iron Load
Ülger, Z., Aydnok, Y., Gürses, D., Levent, E., & Özyürek, A. R. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000212987.18694.5a · Cited by 22
Blood donation, iron depletion and vascular integrity
SULLIVAN, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.013 · Cited by 22
Crosstalk between Iron and Arteriosclerosis
Naito, Y., Tsujino, T., Masuyama, T., & Ishihara, M. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17060 · Cited by 20
Tantawy, A. A. G., Adly, A. A. M., Ismail, E. A. R., Youssef, O. I., & Ali, M. E. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.06.001 · Cited by 21
Cardioprotective Potential of Iron Chelators and Prochelators
Jansová, H., & Šimůnek, T. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170920155439 · Cited by 21
Farkas, E., Bátka, D., Kremper, G., & Pócsi, I. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.03.006 · Cited by 21
Hattori, N., Schnell, O., Bengel, F. M., Rihl, J., Nekolla, S. G., Drzezga, A. E., Standl, E., & Schwaiger, M. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0799-0 · Cited by 21
Iron Chelation and Vascular Function: In Search of the Mechanisms
Ferrara, D. E., & Taylor, W. R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000189303.45609.1f · Cited by 21
Modification of fibrin structure as a possible cause of thrombolytic resistance
Lipiński, B. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0367-6 · Cited by 20
Environmental Toxins and the Heart
Rahnama‐Moghadam, S., Hillis, L. D., & Lange, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416595-3.00003-7 · Cited by 22
Iron chelators for acute stroke
van der Loo, L. E., Aquarius, R., Teernstra, O., Klijn, C. J. M., Menovsky, T., van Dijk, J. M. C., Bartels, R., & Boogaarts, H. D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009280.pub3 · Cited by 20
Kotamraju, S., Tampo, Y., Kalivendi, S. V., Joseph, J., Chitambar, C. R., & Kalyanaraman, B. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.037 · Cited by 20
Emri, T., Tóth, V., Nagy, C. T., Nagy, G., Pócsi, I., Gyémánt, G., Antal, K., Balla, J., Balla, G., Román, G., et al. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6029 · Cited by 19
Pisano, G., Lombardi, R., & Fracanzani, A. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050675 · Cited by 19
The effect of iron status on vascular health
Yunker, L. M., Parboosingh, J. S., Conradson, H. E., Faris, P., Bridge, P. J., Buithieu, J., Title, L. M., Charbonneau, F., Verma, S., Lonn, E., et al. (2006) · Vascular Medicine · doi:10.1191/1358863x06vm656oa · Cited by 19
Zacharski, L. R., Chow, B. K., Howes, P. S., Lavori, P. W., & Shamayeva, G. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.027 · Cited by 19
Navidi, M., Mohhebi, S., Nematbakhsh, M., Roozbehani, S., Talebi, A., Pezeshki, Z., Eshraghi-Jazi, F., Mazaheri, S., Shirdavani, S., Gharagozloo, M., et al. (2014) · Europe PMC (PubMed Central) · Cited by 18
Can Iron Chelators Influence the Progression of Atherosclerosis?
Marx, J. J. M., Kartikasari, A. E. R., & Georgiou, N. (2008) · Hemoglobin · doi:10.1080/03630260701726871 · Cited by 18
Kaphan, É., Laurin, D., Lafeuillade, B., Drillat, P., & Park, S. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100649 · Cited by 17
Iron stores in regular blood donors in Lagos, Nigeria
Akinbami, A., Adediran, Uche, Damulak, D., Adeyemo, & Akanmu (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s42210 · Cited by 17
Shi, Y., Zhou, L., Huang, L., Lian, Y. T., Zhang, X. M., Guo, H., Wu, T., Cheng, L., & He, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.040 · Cited by 16
Sorond, F. A., Shaffer, M. L., Kung, A. L., & Lipsitz, L. A. (2008) · Clinical Science · doi:10.1042/cs20080320 · Cited by 17
Treatment of Anemia in Heart Failure
Jelani, Q., & Katz, S. D. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181e71150 · Cited by 17
Burke, W., Reyes, M. P., & Imperatore, G. (2002) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(02)90002-2 · Cited by 17
Iron, Human Growth, and the Global Epidemic of Obesity
Sangani, R. G., & Ghio, A. J. (2013) · Nutrients · doi:10.3390/nu5104231 · Cited by 15
Deferiprone Stimulates Aged Dermal Fibroblasts via HIF-1α Modulation
Pagani, A., Kirsch, B. M., Hopfner, Ú., Aitzetmüller, M. M., Brett, E. A., Thor, D., Mela, P., Machens, H., & Duscher, D. (2020) · Aesthetic Surgery Journal · doi:10.1093/asj/sjaa142 · Cited by 16
Hashemi, M., Shirzadi, E., Talaei, Z., Moghadas, L., Shaygannia, I., Yavari, M., Amiri, N., Taheri, H., Montazeri, H. R., & Shamsolkottabi, H. (2007) · PubMed Central · Cited by 16
An emerging double‑edged sword role of ferroptosis in cardiovascular disease (Review)
Qin, S., Zhu, C., Chen, C., Sheng, Z., & Cao, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5457 · Cited by 15
Jiang, M., Xu, X., & Zhu, G. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45117 · Cited by 15
SGK1 contributes to ferroptosis in coronary heart disease through the NEDD4L/NF-κB pathway
Peng, Y., Jiang, Y., Zhou, Q., Jia, Z., & Tang, H. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.09.001 · Cited by 15
Brunetti, N. D., Padalino, R., Gennaro, L. D., Cuculo, A., Ziccardi, L., Pellegrino, P. L., & Biase, M. D. (2008) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0248-4 · Cited by 15
Deferoxamine-fibrin accelerates angiogenesis in a rabbit model of peripheral ischemia
Chekanov, V. S., Zargarian, M., Байбеков, И. М., Karakozov, P., Tchekanov, G. V., HARE, J. W., Nikolaychik, V. V., BAJWA, T. K., & Akhtar, M. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm491oa · Cited by 16
Sakuma, S., Ishimura, M., Yuba, Y., Itoh, Y., & Fujimoto, Y. (2018) · Europe PMC (PubMed Central) · Cited by 15
The potential role of ferroptosis in COVID-19-related cardiovascular injury
Yang, L., Wu, Y., Jin, W., Mo, N., Ye, G., Su, Z., Tang, L., Wang, Y., Li, Y., & Du, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115637 · Cited by 15
Barad, A., Clark, A. G., O'Brien, K. O., & Pressman, E. K. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034991 · Cited by 17
Association of serum ferritin with coronary artery disease
Zhou, Y., Liu, T., Tian, C., Kang, P., & Jia, C. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.013 · Cited by 14
The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation
Potor, L., Sikura, K. É., Hegedüs, H., Pethő, D., Szabó, Z., Szigeti, Z. M., Pócsi, I., Trencsényi, G., Szikra, D., Garai, I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134746 · Cited by 14
Association of total iron binding capacity with coronary artery disease
Kang, P., Liu, T., Tian, C., Zhou, Y., & Jia, C. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.05.018 · Cited by 14
Reduced Iron Stores and Its Effect on Vasovagal Syncope (Simple Faint)
Stewart, J. M. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.03.010 · Cited by 14
Iron and Atherosclerosis: Nailing Down a Novel Target with Magnetic Resonance
Sharkey‐Toppen, T., Tewari, A. K., & Raman, S. V. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9551-y · Cited by 16
Sengoelge, G., Rainer, V., Kletzmayr, J., Jansen, M., Derfler, K., Födinger, M., Hörl, W. H., & Sunder–Plassmann, G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00731.x · Cited by 14
Guo, S., Mao, X., Li, X., & Ouyang, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-22275-0 · Cited by 13
Iron-induced remodeling in cultured rat pulmonary artery endothelial cells
Gorbunov, N. V., Atkins, J. L., Gurusamy, N., & Pitt, B. R. (2011) · BioMetals · doi:10.1007/s10534-011-9498-2 · Cited by 13
Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells
Guillemot, J., Asselin, M., Susan‐Resiga, D., Essalmani, R., & Seidah, N. G. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500467 · Cited by 14
Zacharski, L. R., & Gerhard, G. S. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm492ed · Cited by 13
Nassef, S., Shenoufy, M. E., Rawi, R., Demerdash, D. M. E., Hassan, M. H., Mustafa, H., Mattar, M., & Husseiny, N. M. E. (2020) · Journal of Vascular Research · doi:10.1159/000506518 · Cited by 12
Xiao, L., Luo, G., Li, H., Yao, P., & Tang, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159004 · Cited by 12
Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature
Mousavi‐Aghdas, S. A., Farashi, E., & Naderi, N. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00619-z · Cited by 12
Sahin, C., Başaran, Ö., Altun, İ., Akın, F., Topal, Y., Topal, H., Biteker, M., & Azik, F. M. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2293w · Cited by 11
Zhang, S., Ntasis, E., Kabtni, S., van den Born, J., Navis, G. J., Bakker, S. J. L., Krämer, B. K., Yard, B. A., & Hauske, S. J. (2015) · Journal of Diabetes Research · doi:10.1155/2016/8710432 · Cited by 11
Jahn, M., Mrestani, Y., Langguth, P., & Neubert, R. H. H. (2007) · Electrophoresis · doi:10.1002/elps.200600559 · Cited by 11
Associations of plasma hepcidin with mortality risk in patients with coronary artery disease
Li, X., Ding, D., Zhang, Y., Su, D., Wang, M., Chen, X., Yang, Y., Hong, C.-J., Hu, G., & Ling, W. (2017) · Oncotarget · doi:10.18632/oncotarget.22722 · Cited by 11
Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target
Yu, S., Pang, Z., Fang, H., & Liu, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00420-9 · Cited by 13
Fukami, K., Yamagishi, S., Iida, S., Matsuoka, H., & Okuda, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089433 · Cited by 10
Cardiac Drug Development Guide
Pugsley, M. K. (2003) · Humana Press eBooks · doi:10.1385/1592594042 · Cited by 10
Rębacz‐Maron, E., Baranowska‐Bosiacka, I., Gutowska, I., & Chlubek, D. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9578-3 · Cited by 10
Matsumoto, K., YAMAZAKI, M., Satoh, K., Ushio, F., & Endo, K. (2002) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.122.283 · Cited by 10
Barywani, S. B., Thunström, E. Ö., Mandalenakis, Z., & Hansson, P. (2022) · Open Heart · doi:10.1136/openhrt-2021-001928 · Cited by 9
Iron Deficiency in the Acute-Phase Reaction After Open Aortic Surgery
Solìs, J. V., Portero, J. L., Díaz, J. A. P., García, R., Ligero, J. M., Vazquez, E., Lodeiro, C. R., & Ballesteros, L. (2006) · Vascular and Endovascular Surgery · doi:10.1177/1538574406293749 · Cited by 10
Ademosun, A. O., & Oboh, G. (2017) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-017-0279-5 · Cited by 9
Paiman, E. H. M., Louwerens, M., Bresters, D., Westenberg, J. J. M., Tao, Q., van der Geest, R. J., Lankester, A. C., Roest, A. A. W., & Lamb, H. J. (2019) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-018-0513-4 · Cited by 9
Ferroptosis, pathogenesis and therapy in AS co-depression disease
Zhao, Y., Ren, P., Luo, Q., Li, X., Cheng, X., Wen, Y., Wu, X., & Zhou, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1516601 · Cited by 9
Merchant, R. H., Chate, S., Ahmed, J., Ahmad, N., Karnik, A., & Jankaria, B. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.184302 · Cited by 8
Deferiprone increases endothelial nitric oxide synthase phosphorylation and nitric oxide production
Sriwantana, T., Vivithanaporn, P., Paiboonsukwong, K., Rattanawonsakul, K., Srihirun, S., & Sibmooh, N. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0012 · Cited by 8
Chan, W., Kingwell, B. A., Schneider, H. G., Cox, G., Natoli, A., Starr, J., Croft, K. D., Dart, A. M., & Duffy, S. J. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.041 · Cited by 8
Self-citationHomocysteine is Related to Aortic Mineralization in Patients with Ischemic Heart Disease
Peña‐Duque, M. A., González, M. A. B., Valente-Acosta, B., Rodríguez‐Lobato, L. G., Martínez‐Ríos, M. A., Cardoso-Saldaña, G. C., García, R. B., Herrera-Alarcón, V., Linares-López, C., Granados, H. D., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10157 · Cited by 8
Chelation Therapy for Cardiovascular Disease
Halbert, S. C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-728-4_12 · Cited by 8
Paradoxical Effects of Iron Chelation on Growth of Vascular Endothelial Cells
Hodges, Y. K., Reese, S. M., Pahl, P. M. B., & Horwitz, L. D. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000159659.78675.4a · Cited by 8
Quantitative analysis of vascular calcification
Joh, J. H., & Kim, D. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1385 · Cited by 7
Iron Contributes to Endothelial Dysfunction in Acute Ischemic Syndromes
Chekanov, V. S., & Nikolaychik, V. V. (2002) · Circulation · doi:10.1161/circ.105.4.e35 · Cited by 7
Thyroid Function and Serum Ferritin Levels: The Study of Health in Pomerania
Völzke, H., Wallaschofski, H., Wolff, B., Berger, K., John, U., & Dörr, M. (2006) · Thyroid · doi:10.1089/thy.2006.16.681 · Cited by 7
Hoekstra, K. A., Godin, D. V., Kurtu, J., & Cheng, K. M. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1025555525661 · Cited by 7
Kleschyov, A. L., Hubert, G., Münzel, T. F., Stoclet, J., & Bucher, B. (2002) · BMC Pharmacology · doi:10.1186/1471-2210-2-3 · Cited by 7
Metadata
- Authors
- Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., Gokce, N., Keaney, J. F., & Vita, J. A.
- Affiliations
- Boston University (US)
- Venue
- Circulation
- Published
- 2001-06-12
- Volume
- 103
- Issue
- 23
- Pages
- 2799-2804
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2006984835
- Cited by
- 271
- References
- 34
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 9 · 2021: 8 · 2020: 10 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 11 · 2013: 11 · 2012: 12
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (5r01hl052936-04, 5r01hl059346-02, 1r01hl053398-01a1)
- Medical Research Council
- National Health and Medical Research Council
- National Medical Research Council
- National Heart, Lung, and Blood Institute (K23 HL 04425, HL59346, HL 53398, HL 55993, P01HL055854, HL-100088, HL58976, R01HL058976, HL-55854, K23HL004425, P50HL055993, HL-52936)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- iron chelation, deferoxamine, endothelial dysfunction, coronary artery disease, nitric oxide, endothelium-dependent vasodilation, oxidative stress, hydroxyl radicals, Fenton reaction, atherosclerosis, methacholine responsiveness, forearm resistance vessels, L-NMMA
- MeSH terms
- Adult, Blood Flow Velocity, Coronary Disease, Deferoxamine, Endothelium, Vascular, Enzyme Inhibitors, Female, Forearm, Humans, Infusions, Intra-Arterial, Iron, Iron Chelating Agents, Male, Middle Aged, Nitroprusside, Plethysmography, Vasodilation, Vasomotor System, Free Radical Scavengers, Methacholine Chloride, Nitric Oxide Synthase, omega-N-Methylarginine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review